Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Australia.
The ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
J Adolesc Young Adult Oncol. 2020 Dec;9(6):667-671. doi: 10.1089/jayao.2019.0172. Epub 2020 May 12.
Two thirds of metastatic osteosarcoma patients die within 5 years of diagnosis. Improved experimental models of osteosarcoma metastasis will facilitate the development of more effective therapies. Intravenous cancer cell injection can produce lung metastases in nude mice, but this "experimental metastasis" technique has been predominantly applied to a single osteosarcoma cell line (143B) and required injection of 1-2 million cells. Using two human osteosarcoma cell lines, we discovered that transient Natural Killer cell depletion dramatically enhanced the efficiency of experimental pulmonary osteosarcoma metastasis. This technique for modeling osteosarcoma metastasis may enable the identification of better treatments for this aggressive cancer.
三分之二的骨肉瘤转移患者在诊断后 5 年内死亡。改进骨肉瘤转移的实验模型将有助于开发更有效的治疗方法。静脉注射癌细胞可在裸鼠中产生肺转移,但这种“实验性转移”技术主要应用于单一骨肉瘤细胞系(143B),需要注射 100 万至 200 万个细胞。我们使用两种人骨肉瘤细胞系发现,短暂的自然杀伤细胞耗竭显著提高了实验性肺骨肉瘤转移的效率。这种骨肉瘤转移建模技术可能有助于确定针对这种侵袭性癌症的更好治疗方法。